With the UAE health authorities granting regulatory approval to Gilead Sciences to use remdesivir in COVID-19 patients, we take a closer look at its role in the recovery process.
In an exclusive interview with Dubai Eye on One, Frederico Silva, General Manager at Gilead for the Middle East region, explains what remdesivir actually does.
He also explained at what stage a COVID-19 patient should be given the drug.
Silva also touched upon the talks Gilead is having with the UAE Ministry of Health.
Talking about the pricing, he explained how Gilead has come up with two approaches - one for less developed countries and the second for developed nations.


Dubai to expand bus and taxi lanes as public transport ridership grows by 7.4%
Emir of Qatar welcomed by UAE President on visit to Abu Dhabi
UAE, Egypt Foreign Ministers discuss Gaza peace plan
UAE, Pakistan leaders discuss boosting economic ties
UAE, Bosnia FMs discuss strengthening bilateral relations
H.H. Sheikh Mohammed launches campaign to rescue 5 million children from hunger
Dubai advances measures to support people of determination
Abu Dhabi Crown Prince to lead UAE delegation at AI Impact Summit in India
Over 14 million Captagon pills, hidden in grain sacks, seized in UAE–Kuwait operation
Remote learning on Fridays during Ramadan for UAE public schools
UAE clarifies enrollment rules for British curriculum schools
UAE announces temporary road closures in Al Dhaid
Umm Al Emarat aid ship sets sail for Gaza Strip
UAE announces Ramadan working hours for private sector
H.H. Sheikh Hamdan highlights nation’s defence vision at naval college ceremony
Members of UAE's National Identity Committee unveiled
Ramadan working hours confirmed for UAE public sector
Kazakhstan crowned champions of UAE SWAT Challenge 2026
H.H. Sheikh Mohammed attends final day of UAE SWAT Challenge
UAE chairs Arab League emergency meeting on Israeli settlement expansion
